|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00364663 |
|
Date of registration:
|
15/08/2006 |
|
Primary sponsor: |
|
|
Public title:
|
The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer
|
|
Scientific title:
|
The Utility and Cost-Effectiveness Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in Staging Potential Operable Non-Small Cell Lung Cancer |
|
Date of first enrolment:
|
August 2006 |
|
Target sample size:
|
100 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00364663 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Cross-Sectional, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
Taiwan
| | | | | | | |
|
Contacts
|
|
Name:
|
Ruoh-Fang Yen, MD, PhD |
|
Address:
|
|
|
Telephone:
|
886-2-23123456 |
|
Email:
|
rfyen@ha.mc.ntu.edu.tw |
|
Affiliation:
|
|
|
|
Name:
|
Ruoh-Fang Yen, MD, PhD |
|
Address:
|
|
|
Telephone:
|
886-2-23123456 |
|
Email:
|
rfyen@ha.mc.ntu.edu.tw |
|
Affiliation:
|
|
|
|
Name:
|
Ruoh-Fang Yen, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
National Taiwan University Hospital |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patients with non-small-cell lung cancer
Exclusion Criteria:
- patients who are pregnant
- patients who are under 18 years old
- patients who do not undergone surgery
- patients who have other known malignancy
Age minimum:
18 Years
Age maximum:
90 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Non Small Cell Lung Cancer
|
|
Secondary ID(s)
|
|
950307
|
|
NSC 95-2314-B-002 –268 –MY2
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|